Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients

Journal of Clinical Oncology

Volumn 11, Issue 11, 1993, Pages 2127-2135

  Huizing, M T ^a   Keung, A C F ^a   Rosing, H ^a   Van der Kuij, V ^a   Ten Bokkel Huinink, W W ^a   Mandjes, I M ^a   Dubbelman, A C ^a   Pinedo, H M ^a   Beijnen, J H ^a  

^a Department of Medical Oncology ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; PACLITAXEL; PLATINUM; TAXANE DERIVATIVE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; FEMALE; HUMAN; OVARY CARCINOMA; PLASMA CLEARANCE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0027494879     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1993.11.11.2127     Document Type: Article

References (0)